An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Amy F T Arnsten und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Amyloid beta-Peptides, Inflammation. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Knight ADRC Developmental Projects and the Tracy Family SILQ Center.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) research is a large and burgeoning field, where varied methodological approaches are providing multifaceted, but sometimes contradictory, views on the etiology and progression of pathology. The current review aims to summarize and integrate these findings to provide greater coherence to an increasingly splintered field. We provide an overview of the findings from each subfield (neuropathology, positron emission tomography imaging, fluid biomarkers, genetics, transcriptomics/proteomics), highlighting the strengths and weaknesses of each approach and, where possible, trying to resolve discrepancies between subfields. In particular, we address arguments about whether amyloid versus tau initiates pathology, and integrate nanoscale data from aging macaques to improve clarity regarding the earliest pathological stages, as initial phosphorylation events can be lost post mortem in human tissue. We find that Aβ 42 , phosphorylated tau, and inflammation/excessive calcium can all interact in feedforward cycles to drive AD pathology. Increasing cohesion across subdisciplines will strengthen our understanding of this devastating disease. Highlights AD research is an expansive field, where subfields often diverge. The current review integrates across approaches to give a more cohesive view. Many methods cannot detect the earliest changes in brain. The new fluid biomarker pT217Tau shows that soluble tau pathology begins early. Relating amyloid/tau pathologies to inflammation is key for understanding sporadic AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, USA.
- Clinical Neuroanatomy/Department of Neurology, Center for Biomedical Research, University of Ulm, Ulm, Germany.
- Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
- Allen Institute for Brain Science, Seattle, Washington, USA.
- Department of Statistics, University of Washington, Northeast Stevens Way, Seattle, Washington, USA.
- Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- Knight ADRC Developmental Projects and the Tracy Family SILQ Center
- Alzheimer's Association Research
- Coins for Alzheimer's Research Trust
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Arnsten, A. F. T., Del Tredici, K., Barthélemy, N. R., Gabitto, M., van Dyck, C. H., Lein, E., Braak, H., & Datta, D. (2025). An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70404
Vancouver
Arnsten AFT, Del Tredici K, Barthélemy NR, Gabitto M, van Dyck CH, Lein E, et al. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70404
BibTeX
@article{Arnsten2025,
author = {Arnsten, Amy F T and Del Tredici, Kelly and Barthélemy, Nicolas R and Gabitto, Mariano and van Dyck, Christopher H and Lein, Edward and Braak, Heiko and Datta, Dibyadeep},
title = {An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70404}
}
EUVIMED